With Probiotics, Resistance Is Not Always Futile

Cell Host and Microbe

Volumn 24, Issue 3, 2018, Pages 334-336

  Severyn, Christopher J ^a   Bhatt, Ami S ^b  

^a LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC ASSOCIATED DIARRHEA; BIFIDOBACTERIUM; CLOSTRIDIUM DIFFICILE INFECTION; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; FECES MICROFLORA; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LACTOBACILLUS; MICROBIAL COLONIZATION; NONHUMAN; ORGANISMAL INTERACTION; PRIORITY JOURNAL; SHORT SURVEY; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIUM; DRUG EFFECT; GASTROINTESTINAL DISEASE; GROWTH, DEVELOPMENT AND AGING; INTESTINE FLORA; MICROBIOLOGY; PHYSIOLOGY;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL PHYSIOLOGICAL PHENOMENA; DYSBIOSIS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MICROBIOME; HOST MICROBIAL INTERACTIONS; HUMANS; PROBIOTICS;

EID: 85052744878     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2018.08.014     Document Type: Short Survey

References (11)

1. Baktash, A., Terveer, E.M., Zwittink, R.D., Hornung, B.V.H., Corver, J., Kuijper, E.J., Smits, W.K., Mechanistic insights in the success of fecal microbiota transplants for the treatment of Clostridium difficile infections. Front. Microbiol., 9, 2018, 1242.
2. Bernaola Aponte, G., Bada Mancilla, C.A., Carreazo Pariasca, N.Y., Rojas Galarza, R.A., Probiotics for treating persistent diarrhoea in children. Cochrane Database Syst. Rev., 2013, 10.1002/14651858.CD007401.pub2 CD007401.
3. Dethlefsen, L., Relman, D.A., Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc. Natl. Acad. Sci. USA 108:Suppl 1 (2011), 4554–4561.
4. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S.R., Nelson, K.E., Relman, D.A., Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
5. Goldenberg, J.Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., Johnston, B.C., Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst. Rev., 2015, 10.1002/14651858.CD004827.pub4 CD004827.
6. Hickson, M., D'Souza, A.L., Muthu, N., Rogers, T.R., Want, S., Rajkumar, C., Bulpitt, C.J., Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. BMJ, 335, 2007, 80.
7. Smith, P., Willemsen, D., Popkes, M., Metge, F., Gandiwa, E., Reichard, M., Valenzano, D.R., Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife, 6, 2017, e27014.
8. Suez, J., Zmora, N., Zilberman-Schapira, G., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Brik, R.B.-Z., Federici, S., et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell 174 (2018), 1406–1423.
9. Tropini, C., Moss, E.L., Merrill, B.D., Ng, K.M., Higginbottom, S.K., Casavant, E.P., Gonzalez, C.G., Fremin, B., Bouley, D.M., Elias, J.E., et al. Transient osmotic perturbation causes long-term alteration to the gut microbiota. Cell 173 (2018), 1742–1754.e17.
10. Zion Market Research. (2018). Global Probiotic Market Is Set For Rapid Growth and is Expected To Reach Value Around USD 65.87 Billion by 2024. https://www.zionmarketresearch.com/news/probiotics-market.
11. Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R.B.-Z., et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174 (2018), 1388–1405.